Dylan joined Irving Levin in October 2018 as a Research and Editorial Associate and is responsible for reporting on mergers and acquisitions in the healthcare sector. He graduated from Alfred University in May 2014 with a degree in English and Political Science. He currently lives in Bridgeport, CT with his fiancé and his overweight cat, Kimba, and in his free time he plays video games, reads, writes, and hikes on the weekends all year around.
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date... Read More »
MEDNAX, Inc. (NYSE: MD) announced its second major sale of 2020 last week. After divesting its anesthesiology group, American Anesthesiology, Inc., to North American Partners in Anesthesia for $50 million in May, the physician-led health care organization... Read More »
Bristol Hospice, a portfolio company of Webster Equity Partners, is now the leading hospice provider in California, adding Health Essentials, LLC (d/b/a Remita Health) for an undisclosed sum. SV Health Investors, Petra Capital Partners and Bessemer Ventures are all... Read More »
WELL Health Technologies Corp. (TSX.V: WELL), a Vancouver-based digital health company, has moved into the U.S. healthcare market. The company has made several acquisitions in Canada and has a sizeable market presence there; WELL Health owns and operates 20 primary... Read More »
Gilead Sciences, Inc. (NASDAQ: GILD) kicked off this week with a multi-billion acquisition of Immunomedics (NASDAQ: IMMU). The pharmaceutical giant reached an agreement to buy Immunomedics for $21 billion, or $88 per share, a 108% premium to Immunomedics’ closing... Read More »